Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizia Bonadonna

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerationsPatrizia Bonadonna, David Gonzalez-de-Olano, Roberta Zanotti, et al.
The World Allergy Organization Journal|November 27, 2019
Efficacy and safety of honeybee and wasp tyrosine-adsorbed venom immunotherapyMaurizio Severino, Livio Simioni, Patrizia Bonadonna, et al.
International Journal of Molecular Sciences|December 2, 2020
Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized MedicinePeter Valent, Cem Akin, Boguslaw Nedoszytko, et al.
Bone|July 26, 2011
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosisMaurizio Rossini, Roberta Zanotti, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology|January 13, 2009
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levelsPatrizia Bonadonna, Omar Perbellini, Giovanni Passalacqua, et al.
International Archives of Allergy and Immunology|July 1, 2019
Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation SyndromePeter Valent, Patrizia Bonadonna, Karin Hartmann, et al.
Clinical Case Reports|December 12, 2017
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosisMassimiliano Bonifacio, Roberta Zanotti, Emanuele Guardalben, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 13, 2022
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and ManagementNicoletta Luxi, Alexia Giovanazzi, Alessandra Arcolaci, et al.
Allergy|November 10, 2020
Practice parameters for diagnosing and managing iodinated contrast media hypersensitivityMaría José Torres, Axel Trautmann, Ingrid Böhm, et al.
Vaccine|June 6, 2025
A real-life multicenter experience for the post-pandemic management of hypersensitivity reactions to Covid-19 vaccinesAlessandra Arcolaci, Lucia Guidolin, Elisa Olivieri, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerationsPatrizia Bonadonna, David Gonzalez-de-Olano, Roberta Zanotti, et al.
The World Allergy Organization Journal|November 27, 2019
Efficacy and safety of honeybee and wasp tyrosine-adsorbed venom immunotherapyMaurizio Severino, Livio Simioni, Patrizia Bonadonna, et al.
International Journal of Molecular Sciences|December 2, 2020
Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized MedicinePeter Valent, Cem Akin, Boguslaw Nedoszytko, et al.
Bone|July 26, 2011
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosisMaurizio Rossini, Roberta Zanotti, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology|January 13, 2009
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levelsPatrizia Bonadonna, Omar Perbellini, Giovanni Passalacqua, et al.
International Archives of Allergy and Immunology|July 1, 2019
Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation SyndromePeter Valent, Patrizia Bonadonna, Karin Hartmann, et al.
Clinical Case Reports|December 12, 2017
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosisMassimiliano Bonifacio, Roberta Zanotti, Emanuele Guardalben, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 13, 2022
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and ManagementNicoletta Luxi, Alexia Giovanazzi, Alessandra Arcolaci, et al.
Allergy|November 10, 2020
Practice parameters for diagnosing and managing iodinated contrast media hypersensitivityMaría José Torres, Axel Trautmann, Ingrid Böhm, et al.
Vaccine|June 6, 2025
A real-life multicenter experience for the post-pandemic management of hypersensitivity reactions to Covid-19 vaccinesAlessandra Arcolaci, Lucia Guidolin, Elisa Olivieri, et al.
Pageof 12